The shares of ARRIS International plc (NASDAQ:ARRS) started off the last trading session with the price of $26.98 while closing the day with the price of $27.19. The shares of ARRIS International plc (NASDAQ:ARRS) Rise 0.78% with the Gain of 0.21 points.
The shares of ARRIS International plc (NASDAQ:ARRS) traded with the day volume of 2.15 Million shares whereas its average trading volume is 1.61 Million.
While analyzing the past performance of the stock we can see that the shares of ARRIS International plc (NASDAQ:ARRS) Loss -1.88% in the last week while rising 9.77% in the last month. Past quarter performance shows the red light with -5.49%. The semi-annual and annual performance shows 0.15% and 4.46% respectively.
Some critical values of the shares of ARRIS International plc (NASDAQ:ARRS) to be discussed here are: the beta which shows the value at 1.24 while Average True Range of ARRIS International plc (NASDAQ:ARRS) demonstrate the value at 0.73. The weekly and monthly volatility of the shares of ARRIS International plc (NASDAQ:ARRS) are indicated at 2.18% and 2.76%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 59.35.
While studying the financial position of the shares of ARRIS International plc (NASDAQ:ARRS), we can see that the Market capitalization of the company is at 5.05 Billion. The shares outstanding for the company is 185.58 Million and the shares float stands at 175.51 Million. The income of the company stand at 69.5 Million while the sales stand at 6.61 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.37, Price to Earnings or P/E is at 73.69, Price to Sales P/S show the value of 0.76, the Return on Asset ROA stood at 0.012 and the Return on Equity ROE depicted at 0.029 while Return on Investment ROI is at 0.027.
TG Therapeutics, Inc. (NASDAQ:TGTX)
TG Therapeutics, Inc. (NASDAQ:TGTX) started its previous trading session at $16.35 and closed at $16.2 showing a Fell of -1.52 Percent.
The Company traded with an average Volume of 1.6 Million whereas, its Day Volume stood at 2.14 Million.
Looking at the performance of the stock, TG Therapeutics, Inc. (NASDAQ:TGTX) Loss -2.11% in the last week in its shares price and 30.12% in the last month. Quarterly performance shows a green of 97.56 Percent while Semi-Annual and Annual performances shows a 36.13 and 16.55 percent respectively.
Beta for TG Therapeutics, Inc. (NASDAQ:TGTX) stands at 1.21 while the ATR (average true range) is at 0.91. The Stock’s Weekly and Monthly Volatility is 4.50% and 6.28% respectively showing a RSI value of 70.32.
While studying the financial position of the shares of TG Therapeutics, Inc. (NASDAQ:TGTX), we can see that the Market capitalization of the company is at 1.16 Billion. The shares outstanding for the company is 71.74 Million and the shares float stands at 56.54 Million.
The Company generated an income of -118500000 and the sales of 200000 in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.92 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 5810.94 respectively.
The Return on Assets stands at -1.119, ROE shows a value of -1.456 and ROI for TG Therapeutics, Inc. (NASDAQ:TGTX) is 0 as of Trailing Twelve Months period.
